Search

CC-99282: A phase 1 trial of CC-99282 alone and in combination with anti-lymphoma agents in people with relapsed or refractory non-Hodgkin lymphoma

Trial

… back (relapsed) or not responded to previous treatment (refractory). This is a phase 1 (early phase) trial . Little … non-Hodgkin Lymphoma (NHL) which has relapsed or become refractory to treatment may be eligible for this trial. … 1/2 trial evaluating CC-99282 in people with relapsed or refractory non-Hodgkin lymphoma. You can share the following …

BELLWAVE-010: A phase 3 trial of nemtabrutinib and venetoclax in people with relapsed or refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma

Trial

… in combination with venetoclax in people with relapsed or refractory CLL and SLL. Participants in the trial will either … Who can enter Adults with CLL or SLL which has become refractory to, or has relapsed after at least one prior … which has returned after (relapsed) or not responded to (refractory) treatment. You can share the following …